3-69119899-ATCTTCT-ATCTTCTTCT
Variant names:
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP3BP6_ModerateBS1
The NM_198271.5(LMOD3):c.453_455dupAGA(p.Glu151dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000384 in 1,456,444 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000053 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000037 ( 0 hom. )
Consequence
LMOD3
NM_198271.5 disruptive_inframe_insertion
NM_198271.5 disruptive_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.372
Publications
0 publications found
Genes affected
LMOD3 (HGNC:6649): (leiomodin 3) The protein encoded by this gene is a member of the leiomodin family of proteins. This protein contains three actin-binding domains, a tropomyosin domain, a leucine-rich repeat domain, and a Wiskott-Aldrich syndrome protein homology 2 domain (WH2). Localization of this protein to the pointed ends of thin filaments has been observed, and there is evidence that this protein acts as a catalyst of actin nucleation, and is important to the organization of sarcomeric thin filaments in skeletal muscles. Mutations in this gene have been associated as one cause of Nemaline myopathy, as other genes have also been linked to this disorder. Nemaline myopathy is a disorder characterized by nonprogressive generalized muscle weakness and protein inclusions (nemaline bodies) in skeletal myofibers. Patients with mutations in this gene often present with a severe congenital form of the disorder. [provided by RefSeq, Jan 2015]
LMOD3 Gene-Disease associations (from GenCC):
- nemaline myopathy 10Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
- typical nemaline myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- severe congenital nemaline myopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -7 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_198271.5
BP6
Variant 3-69119899-A-ATCT is Benign according to our data. Variant chr3-69119899-A-ATCT is described in ClinVar as Likely_benign. ClinVar VariationId is 1154579.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000053 (8/151066) while in subpopulation EAS AF = 0.00156 (8/5144). AF 95% confidence interval is 0.000773. There are 0 homozygotes in GnomAd4. There are 8 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| LMOD3 | NM_198271.5 | c.453_455dupAGA | p.Glu151dup | disruptive_inframe_insertion | Exon 2 of 3 | ENST00000420581.7 | NP_938012.2 | |
| LMOD3 | NM_001304418.3 | c.453_455dupAGA | p.Glu151dup | disruptive_inframe_insertion | Exon 3 of 4 | NP_001291347.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| LMOD3 | ENST00000420581.7 | c.453_455dupAGA | p.Glu151dup | disruptive_inframe_insertion | Exon 2 of 3 | 1 | NM_198271.5 | ENSP00000414670.3 | ||
| LMOD3 | ENST00000475434.1 | c.453_455dupAGA | p.Glu151dup | disruptive_inframe_insertion | Exon 3 of 4 | 5 | ENSP00000418645.1 | |||
| LMOD3 | ENST00000489031.5 | c.453_455dupAGA | p.Glu151dup | disruptive_inframe_insertion | Exon 3 of 4 | 2 | ENSP00000417210.1 |
Frequencies
GnomAD3 genomes AF: 0.0000530 AC: 8AN: 151066Hom.: 0 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
8
AN:
151066
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000231 AC: 38AN: 164826 AF XY: 0.000242 show subpopulations
GnomAD2 exomes
AF:
AC:
38
AN:
164826
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000368 AC: 48AN: 1305378Hom.: 0 Cov.: 28 AF XY: 0.0000416 AC XY: 27AN XY: 648622 show subpopulations
GnomAD4 exome
AF:
AC:
48
AN:
1305378
Hom.:
Cov.:
28
AF XY:
AC XY:
27
AN XY:
648622
show subpopulations
African (AFR)
AF:
AC:
0
AN:
29796
American (AMR)
AF:
AC:
0
AN:
35796
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
24618
East Asian (EAS)
AF:
AC:
43
AN:
35704
South Asian (SAS)
AF:
AC:
0
AN:
78174
European-Finnish (FIN)
AF:
AC:
0
AN:
49928
Middle Eastern (MID)
AF:
AC:
0
AN:
5500
European-Non Finnish (NFE)
AF:
AC:
2
AN:
990952
Other (OTH)
AF:
AC:
3
AN:
54910
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000530 AC: 8AN: 151066Hom.: 0 Cov.: 31 AF XY: 0.000109 AC XY: 8AN XY: 73694 show subpopulations
GnomAD4 genome
AF:
AC:
8
AN:
151066
Hom.:
Cov.:
31
AF XY:
AC XY:
8
AN XY:
73694
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41070
American (AMR)
AF:
AC:
0
AN:
15160
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3464
East Asian (EAS)
AF:
AC:
8
AN:
5144
South Asian (SAS)
AF:
AC:
0
AN:
4754
European-Finnish (FIN)
AF:
AC:
0
AN:
10374
Middle Eastern (MID)
AF:
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
AC:
0
AN:
67806
Other (OTH)
AF:
AC:
0
AN:
2072
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.538
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Nemaline myopathy 10 Benign:1
Sep 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.